Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Sell
31
HEWA Quote, Financials, Valuation and Earnings
Last price:
$0.08
Seasonality move
:
17.85%
Day range:
$0.08 - $0.08
52-week range:
$0.06 - $0.15
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.17x
P/B ratio:
--
Volume:
--
Avg. volume:
5.3K
1-year change:
-43.22%
Market cap:
$4.1M
Revenue:
$20.3M
EPS (TTM):
-$0.04
Analysts' Opinion
-
Consensus RatingHealthWarehouse.com has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, HealthWarehouse.com has an estimated upside of 766.67% from its current price of $0.08.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $0.08.
Fair Value
-
According to the consensus of 0 analysts, HealthWarehouse.com has 766.67% upside to fair value with a price target of -- per share.
HEWA vs. S&P 500
-
Over the past 5 trading days, HealthWarehouse.com has overperformed the S&P 500 by 9.32% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
HealthWarehouse.com does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
HealthWarehouse.com has grown year-over-year revenues for 2 quarters straight. In the most recent quarter HealthWarehouse.com reported revenues of $9M.
Earnings Growth
-
HealthWarehouse.com has grown year-over-year earnings for 1 quarter straight. In the most recent quarter HealthWarehouse.com reported earnings per share of -$0.00.
Enterprise value:
5.7M
EV / Invested capital:
-2.67x
Price / LTM sales:
0.17x
EV / EBIT:
--
EV / Revenue:
0.23x
PEG ratio (5yr expected):
-3.50x
EV / Free cash flow:
30.39x
Price / Operating cash flow:
22.04x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$12.7M
Return On Assets:
-35.37%
Net Income Margin (TTM):
-4.72%
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
1.53%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $17.4M | $20.3M | $24.8M | $4.8M | $9M | |
| Gross Profit | $11.8M | $12.3M | $12.7M | $2.9M | $3.8M | |
| Operating Income | -$603.9K | -$1.2M | -$924.7K | -$262.5K | $137.7K | |
| EBITDA | -$461.3K | -$814.5K | -$508.8K | -$159K | $240.9K | |
| Diluted EPS | -$0.03 | -$0.04 | -$0.04 | -$0.01 | -$0.00 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $2.9M | $2.7M | -- | $2.5M | |
| Total Assets | -- | $3.7M | $3.6M | -- | $3.7M | |
| Current Liabilities | -- | $5.6M | $5.9M | -- | $5.1M | |
| Total Liabilities | -- | $6.5M | $6.5M | -- | $8M | |
| Total Equity | -- | -$2.8M | -$2.9M | -- | -$4.3M | |
| Total Debt | -- | $2.2M | $2.2M | -- | $2.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$554.9K | -$167K | $226.7K | $162K | $153.8K | |
| Cash From Investing | -$231.6K | -$648.2K | -$94.7K | -$12K | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -$786.5K | -$815.2K | $187K | $150K | $153.8K | |
HEWA
Sector
Market Cap
$4.1M
$348.1M
Price % of 52-Week High
50.37%
73.74%
Dividend Yield
0%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
-43.23%
-12.75%
Beta (5-Year)
0.194
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$0.08
200-day SMA
Sell
Level
$0.10
Bollinger Bands (100)
Sell
Level
0.07 - 0.09
Chaikin Money Flow
Buy
Level
4.9M
20-day SMA
Sell
Level
$0.08
Relative Strength Index (RSI14)
Sell
Level
41.42
ADX Line
Neutral
Level
Williams %R
Buy
Level
-83.3333
50-day SMA
Sell
Level
$0.08
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Sell
Level
-72
On Balance Volume
Neutral
Level
7.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-12.5281)
Sell
CA Score
(Annual)
Level (-7.0781)
Buy
Beneish M-Score
(Annual)
Level (-4.8869)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (16.2559)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (7)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
HealthWarehouse.com Inc is an online pharmacy, licensed and authorized to sell and deliver prescriptions in all 50 United States and the District of Columbia focusing on the out-of-pocket prescription drug market. The company sells directly to individual consumers who purchase prescription medications and over-the-counter (OTC) products over the Internet. It offers a complete range of generic, brand-name, and pet prescription medications as well as OTC medications and products.
Stock Forecast FAQ
In the current month, HEWA has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HEWA average analyst price target in the past 3 months is --.
-
Where Will HealthWarehouse.com Stock Be In 1 Year?
According to analysts, the consensus estimate is that HealthWarehouse.com share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About HealthWarehouse.com?
Analysts are divided on their view about HealthWarehouse.com share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that HealthWarehouse.com is a Sell and believe this share price will drop from its current level to --.
-
What Is HealthWarehouse.com's Price Target?
The price target for HealthWarehouse.com over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HEWA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for HealthWarehouse.com is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of HEWA?
You can purchase shares of HealthWarehouse.com via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase HealthWarehouse.com shares.
-
What Is The HealthWarehouse.com Share Price Today?
HealthWarehouse.com was last trading at $0.08 per share. This represents the most recent stock quote for HealthWarehouse.com. Yesterday, HealthWarehouse.com closed at $0.08 per share.
-
How To Buy HealthWarehouse.com Stock Online?
In order to purchase HealthWarehouse.com stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Lucid vs Rivian Stock: Which Is Best?
Few realize that Lucid Group (NASDAQ: LCID) traces part of…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
